Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for antibodies monoclonal, humanized (compound)
Most Correlated Studies
- Breast tumors with pathologic complete response (pCR) or residual disease (RD) upon chemotherapy
- A431 cells xenografts treated with rapamycin and nimotuzumab
- Sarcoma gene expression in tumors with good and poor responses to bevacizumab treatment
- Peripheral blood cells of rheumatoid arthritis patients receiving anti-TNFa therapy
- CD4+ splenocyte gene expression in response to treatment with teplizumab or hIg
Most Relevant Literature
- Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2.
- Human Antibodies for Viral Infections.
- Cross-reactivity of human monoclonal antibodies with canine peripheral blood mononuclear cells.
- Efficient evolution of human antibodies from general protein language models.
- High throughput identification of human monoclonal antibodies and heavy-chain-only antibodies to tre…
Most Relevant Clinical Trials
- The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV
- Clinical Assessment of Safety and Tolerability of the New Monoclonal Humanized Antibody CaCP29
- A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients With Advanc…
- Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies
- First in Human Study of a Monoclonal Antibody (SOL-116) Targeting BSSL (Bile Salt-Stimulated Lipase)
